Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
L.van LeeuwenN.TavendaleR.BennettA
This once-weekly injection is highly effective, especially for those with obesity or type 2 diabetes, offering significant weight loss and improved health with consistent use and medical guidance
Participants receiving semaglutide showed improvements in inflammatory markers like C-reactive protein, reflecting genuine reductions in visceral fat-driven inflammation rather than just weight loss on a scale
For context, the SURMOUNT-5 trial compared tirzepatide to semaglutide at weight-loss doses (2.4 mg, the Wegovy dose) in people with obesity
US$ 28.94
US$ 25.64
US$ 20.45
/assets/production/practices/3ac665024d1f61d92acdcfa8ac89068ae9a7da02/images/2793316.png)
.png)
US$ 26.30
